Working… Menu

A Study of the Safety and Efficacy of EBV Specific T-cell Lines (EBV-TCL-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02580539
Recruitment Status : Recruiting
First Posted : October 20, 2015
Last Update Posted : September 11, 2020
Information provided by (Responsible Party):
Dr. Jean-Sebastien Delisle, MD, PhD, Maisonneuve-Rosemont Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : August 2022